Brinker Capital Investments, LLC Exagen Inc. Transaction History

Brinker Capital Investments, LLC

  • $5.01 Billion
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
BUY
$2.69 - $8.68 $22,916 - $73,944
8,519 Added 9.4%
99,115 $269,000
Q2 2022

Jul 18, 2022
SELL
$4.18 - $7.74 $10,959 - $20,294
-2,622 Reduced 2.81%
90,596 $520,000
Q1 2022

May 16, 2022
BUY
$7.12 - $11.06 $155,394 - $241,384
21,825 Added 30.57%
93,218 $749,000
Q4 2021

Feb 08, 2022
SELL
$8.97 - $14.08 $438,148 - $687,751
-48,846 Reduced 40.62%
71,393 $830,000
Q2 2021

Aug 03, 2021
BUY
$12.4 - $17.92 $1.49 Million - $2.15 Million
120,239 New
120,239 $1.8 Million

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email